NXF-00
Natrix® Q Micro
Natrix® Q Micro (0.2 mL), pack of 10 devices
Synonym(s):
Natrix® Q Membrane Adsorber
Select a Size
About This Item
Skip To
Product Name
Natrix® Q Micro,
material
media (Macroporous Polymer), polypropylene device
description
Natrix® Q Micro
product line
Natrix®
packaging
pack of 10 × 0.2 mL (devices)
parameter
1-5 mL/min flow rate, 75 psi max. pressure
pore size
0.4 μm pore size
fitting
female inlet and outlet (luer)
application(s)
pharmaceutical
separation technique
strong anion exchange
storage temp.
2-30°C
1 of 4
This Item | |||
|---|---|---|---|
| separation technique strong anion exchange | separation technique strong cation exchange | separation technique strong cation exchange | separation technique strong anion exchange |
| product line Natrix® | product line Natrix® | product line Natrix® | product line Natrix® |
| material media (Macroporous Polymer) | material media (Macroporous Polymer), polypropylene device | material media (Macroporous Polymer), polypropylene device | material - |
| description Natrix® Q Micro | description - | description - | description Natrix® Q Pilot |
| packaging pack of 10 × 0.2 mL (devices) | packaging pack of 10 × 1 mL | packaging pack of 2 × 1 mL | packaging - |
| parameter 1-5 mL/min flow rate | parameter ≤10 MV/min flow rate, 75 psi max. pressure | parameter ≤10 MV/min flow rate, 75 psi max. pressure | parameter 75-375 mL/min flow rate |
General description
Application
Biochem/physiol Actions
Features and Benefits
Packaging
Legal Information
related product
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Free eBook outlines plasmid DNA manufacturing process and downstream purification challenges for various applications.
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
A cost-model compares modalities like viral vectors and mRNA for production scale decision-making.
Related Content
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Learn more on mAb downstream processing, more specifically polishing chromatography and the relevant associated products.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| NXF-00 | 04061841774150 |
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service